1. Bullock, R., and Fujisawa, H. 1992. The role of glutamate antagonists for the treatment of CNS injury. J. Neurotrauma 9:S443–62.

2. Choi, D.W. 1992. Excitotoxic cell death. J. Neurobiol. 23:1261–1276.

3. Gill, R., Foster, A.C., and Woodruff, G.N. 1987. Systematic administration of MK-801 protects against ischemia-induced hippocampal neurodegeneration in the gerbil. J. Neurosci. 1:3343–3349.

4. Gill, R., Brazell, C., Woodruff, G.N., and Kemp, J.A. 1991. The neuroprotective action of dizocilpine (MK-801) in the rat middle cerebral artery occlusion model of focal ischaemia. Br. J. Pharmacol. 103:2030–2036.

5. Olney, J.W., Ikonomidou, C., Mosinger, J.L., and Frierdich, G. 1989. MK-801 prevents hypobaric-ischemic neuronal degeneration in infant rat brain. J. Neurosci. 9:1701–4.

6. Buchan, A.M., Slivka, A., and Zue, D. 1992. The effect of the NMDA receptor antagonist MK-801 on cerebral blood flow and infarct volume in experimental focal stroke. Brain Res. 574:171–177.

7. Corbett, D., Evans, S., Thomas, C., Wang, D., and Jonas, R.A. 1990. MK-801 reduced cerebral ischemic injury by inducing hypothermia. Brain Res. 514:300–304.

8. NellgŒrd, B., Gustafson, I., and Wieloch, T. 1991. Lack of protection by the N-methyl-D-aspartate receptor blocker dizocilpine (MK-801) after transient severe cerebral ischemia in the rat. Anesthesiology 75:279–287.

9. Buchan, A., Li, H., and Pulsinelli, W.A. 1991. The N-methyl-D-aspartate antagonist, MK-801, fails to protect against neuronal damage caused by transient, severe forebrain ischemia in adult rats. J. Neurosci. 11:1049–1056.

10. Levene, M. 1992. Role of excitatory amino acid antagonists in the management of birth asphyxia. Biol. Neonate 62:248–51.

11. Hattori, H., Morin, A.M., Schwartz, P.H., Fujikawa, D.G., and Wasterlain, C.G. 1989. Posthypoxic treatment with MK-801 reduces hypoxic-ischemic damage in the neonatal rat. Neurology 39:713–8.

12. McDonald, J.W., Silverstein, F.S., and Johnston, M.V. 1987. MK-801 protects the neonatal brain from hypoxic-ischemic damage. Eur. J. Pharmacol. 140:359–61.

13. Speiser, Z., Uziel, J., Defrin-Assa, R., Gitter, S., and Urca, G. 1991. Different behavioral deficits are induced by anoxia/hypoxia in neonatal and senescent rats: Blockade by MK-801. Behav. Brain Res. 42:181–186.

14. Dvor‡k, K., and Feit, J. 1977. Migration of neuroblasts through partial necrosis of the cerebral cortex in newborn ratsÑcontribution to the problems of morphological development and developmental period of cerebral microgyria. Acta Neuropathol (Berl) 38:203–212.

15. Dvor‡k, K., Feit, J., and Jur‡nkov‡, Z. 1978. Experimentally induced focal microgyria and status verrucosus deformis in ratsÑPathogenesis and interrelation histological and autoradiographical study. Acta Neuropathol (Berl) 44:121–129.

16. Suzuki, M., and Choi, B.H. 1991. Repair and reconstruction of the cortical plate following closed cryogenic injury to the neonatal rat cerebrum. Acta Neuropathol. (Berl.) 82:93–101.

17. Rosen, G.D., Press, D.M., Sherman, G.F., and Galaburda, A.M. 1992. The development of induced cerebrocortical microgyria in the rat. J. Neuropathol. Exp. Neurol. 51:601–611.

18. Humphreys, P., Rosen, G.D., Press, D.M., Sherman, G.F., and Galaburda, A.M. 1991. Freezing lesions of the newborn rat brain: A model for cerebrocortical microgyria. J. Neuropathol. Exp. Neurol. 50:145–160.

19. Ferrer, I. 1993. Experimentally induced cortical malformations in rats. Child Nerv. Syst. 9:403-407.

20. Barth, P.G., and van der Harten, J.J. 1985. Parabiotic twin syndrome with topical isocortical disruption and gastroschisis. Acta Neuropathol. (Berl.) 67:345–349.

21. Dekaban, A. 1965. Large defects in cerebral hemispheres associated with cortical dysgenesis. J. Neuropathol. Exp. Neurol. 24:512–530.

22. Ferrer, I. 1984. A Golgi analysis of unlayered polymicrogyria. Acta Neuropathol (Berl) 65:69–76.

23. Galaburda, A.M., and Kemper, T.L. 1979. Cytoarchitectonic abnormalities in developmental dyslexia; a case study. Ann. Neurol. 6:94–100.

24. Galaburda, A.M., Sherman, G.F., Rosen, G.D., Aboitiz, F., and Geschwind, N. 1985. Developmental dyslexia: Four consecutive cases with cortical anomalies. Ann. Neurol. 18:222–233.

25. Ho, K.L., Chang, C.H., Yang, S.S., and Chason, J.L. 1984. Neuropathologic findings in thanatophoric dysplasia. Acta Neuropathol. (Berl.) 63:218–228.

26. Levine, D.N., Fisher, M.A., and Caviness, V.S. 1974. Porencephaly with microgyria: A pathologic study. Acta Neuropathol. (Berl.) 29:99–113.

27. Norman, M.G. 1980. Bilateral encephaloclastic lesions in a 26 week gestation fetus: Effect on neuroblast migration. J. Can. Sci. Neurol. 7:191–194.

28. Lyon, G., and Robain, O. 1967. Etude comparative des encŽphalopathies circulatoires prŽnatales et para-natales (hydranencŽphalies, porencŽphalies et encŽphalomalacies kystiques de la substance blanche). Acta Neuropathol (Berl) 9:79–98.

29. McBride, M.C., and Kemper, T.L. 1982. Pathogenesis of four-layered microgyric cortex in man. Acta Neuropathol (Berl) 57:93–98.

30. Richman, D.P., Stewart, R.M., and Caviness, V.S. 1974. Cerebral microgyria in a 27-week fetus: an architectonic and topographic analysis. J. Neuropathol. Exp. Neurol. 33:374–384.

31. Olney, J.W. 1989. Glutamate, a neurotoxic transmitter. J. Child Neurol. 4:218–226.

32. Grimaldi, R., Zoli, M., Agnati, L.F., Ferraguti, F., Fuxe, K., Toffano, G., and Zini, I. 1990. Effects of transient forebrain ischemia on peptidergic neurons and astroglial cells: evidence for recovery of peptide immunoreactivities in neocortex and striatum but not hippocampal formation. Exp. Brain Res. 82:123–136.

33. Grimaldi, R., Zini, I., Ferraguti, F., Cortelli, P., Fuxe, K., Agnati, L.F., and Zoli, M. 1989. Effects of transient forebrain isch¾mia on vasoactive intestinal polypeptide-immunoreactive neuronal populations in the frontoparietal cortex and hippocampal formation of the male rat. Acta Physiol. Scand. 136:289–290.

34. Rosen, G.D., and Harry, J.D. 1990. Brain volume estimation from serial section measurements: A comparison of methodologies. J. Neurosci. Meth. 35:115–124.

35. Fitch, R.H., Tallal, P., Brown, C., Galaburda, A.M., and Rosen, G.D. 1994. Induced microgyria and auditory temporal processing in rats: A model for language impairment? Cereb. Cortex 4:260–270.

36. Von Lubitz, D.K., McKenzie, R.J., Lin, R.C., Devlin, T.M., and Skolnick, P. 1993. MK-801 is neuroprotective but does not improve survival in severe forebrain ischemia. Eur. J. Pharmacol. 233:95–100.

37. Goldman-Rakic, P.S., and Rakic, P. 1984. Experimentally modified convolutional patterns in nonhuman primates: Possible relevance of connections to cerebral dominance in humans. Pages 179–192 in Geschwind, N., and Galaburda, A.M., Ed., Biological Foundations of Cerebral Dominance. Harvard University Press, Cambridge, Massachusetts.

38. Innocenti, G.M., and Berbel, P. 1991. Analysis of an experimental cortical network: i) Architectonics of visual areas 17 and 18 after neonatal injections of ibotenic acid; similarities with human microgyria. J. Neur. Transplant. 2:1–28.

39. Innocenti, G.M., and Berbel, P. 1991. Analysis of an experimental cortical network: ii) Connections of visual areas 17 and 18 after neonatal injections of ibotenic acid. J. Neur. Transplant. 2:29–54.

40. Miller, B., Nagy, D., Finlay, B.L., Chance, B., Kobayashi, A., and Nioka, S. 1993. Consequences of reduced cerebral blood flow in brain development. I. Gross morphology, histology, and callosal connectivity. Exp. Neurol. 124:326–42.

41. Trifiletti, R.R. 1992. Neuroprotective effects of NG-nitro-L-arginine in focal stroke in the 7-day old rat. Eur. J. Pharmacol. 218:197–8.

42. Nozaki, K., and Beal, M.F. 1992. Neuroprotective effects of L-kynurenine on hypoxia-ischemia and NMDA lesions in neonatal rats. J. Cereb. Blood Flow Metab. 12:400–7.

43. Andine, P., Lehmann, A., Ellren, K., Wennberg, E., Kjellmer, I., Nielsen, T., and Hagberg, H. 1988. The excitatory amino acid antagonist kynurenic acid administered after hypoxic-ischemia in neonatal rats offers neuroprotection. Neurosci. Lett. 90:208–12.

44. Silverstein, F.S., Buchanan, K., Hudson, C., and Johnston, M.V. 1986. Flunarizine limits hypoxia-ischemia induced morphologic injury in immature rat brain. Stroke 17:477–82.

45. Zimmerman, J., and Spencer, F. 1959. The influence of hypothermia on cerebral injury resulting from circulatory occlusion. Surg. Forum 9:216–218.

46. Berntman, L., Welsh, F.A., and Harp, J.R. 1981. Cerebral protective effect of low-grade hypothermia. Anesthesiology 55:495–498.

47. Gill, R., and Woodruff, G.N. 1990. The neuroprotective actions of kynurenic acid and MK-801 in gerbils are synergistic and not related to hypothermia. Eur. J. Pharmacol. 176:143–9.

48. Lin, B.W., Dietrich, W.D., Ginsberg, M.D., Globus, M.Y.-T., and Busto, R. 1993. MK-801 (Dizocilpine) protects the brain from repeated normothermic global ischemic insults in the rat. J. Cereb. Blood Flow Metab. 13:925–932.

49. Hattori, H., and Wasterlain, C.G. 1991. Hypothermia does not explain MK-801 neuroprotection in a rat model of neonatal hypoxic-ischemic encephalopathy. Neurology 41:330.